Trans-nasal Humidified Rapid Insufflation Ventilatory Exchange (THRIVE) and its Utility in Otolaryngology, Head and Neck Surgery: A Literature Review

• Published in: Indian journal of otolaryngology, and head, and neck surgery and head, and neck surgery, 2024-04, Vol.76 (2), p.1921-1930
• Main Authors: Ananthapadmanabhan, Saikrishna, Kudpaje, Akshay, Raju, Dinesh, Smith, Mark, Riffat, Faruque, Novakovic, Daniel, Stokan, Murray, Palme, Carsten E.
• Format: Article
• Language: English
• Subjects: Anesthesia; Head and Neck Surgery; Medicine; Medicine & Public Health; Original Article; Otolaryngology; Otorhinolaryngology
• ISSN: 2231-3796; 0973-7707
• DOI: 10.1007/s12070-023-04445-2

High-flow nasal oxygen (HFNO) therapy is extensively used in critical care units for spontaneously breathing patients. Trans-nasal humidified rapid insufflation ventilatory exchange (THRIVE) is a method of apnoeic oxygenation with continuous nasal delivery of warmed, humidified oxygen at high-flow rates up to 70L/min. THRIVE extends the apnoeic window before desaturation occurs so that tubeless anaesthesia is possible. The advent of THRIVE has had a monumental impact on anaesthetic practice, with a diverse range of clinical applications and it has been incorporated into difficult airway guidelines. THRIVE has many applications in otolaryngology and head and neck surgery. It is used as a pre-oxygenation tool during induction in both anticipated and unanticipated difficult airway scenarios and as a method of oxygenation for tubeless anaesthesia in elective laryngotracheal and hypopharyngeal surgeries and during emergence from anaesthesia. In this scoping review of the literature, we aim to provide an overview on the utility of THRIVE in otolaryngology, including the underlying physiologic principles, current indications and limitations, and its feasibility and safety in different surgical contexts and specific population groups.